Crinetics Pharmaceuticals, Inc. (CRNX) › Capital ExpendituresCrinetics Pharmaceuticals, Inc. (CRNX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $190.0K2017: $304.0K2018: $1.06M2019: $492.0K2020: $186.0K2021: $436.0K2022: $1.66M2023: $4.69M2024: $3.84M2025: $5.76M$5.76M2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$5.76M+49.9%2024$3.84M-18.0%2023$4.69M+183.1%2022$1.66M+279.8%2021$436.0K+134.4%2020$186.0K-62.2%2019$492.0K-53.5%2018$1.06M+248.4%2017$304.0K+60.0%2016$190.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share